Table 1.
Biological processes | Molecular pathology | Disease | References | Gene | |
---|---|---|---|---|---|
Signal transduction | Ras signal pathway | Type I neurofibromatosis | [98–101] | NF1 | [117, 118] |
Noonan syndrome | [102, 103] | BRAF | [119] | ||
KRAS | |||||
PTPNII | |||||
RAFI | |||||
SOSII | |||||
Costello syndrome | [104, 105] | HRAS | [120] | ||
Notch signal pathway | Alagille syndrome | [106, 107] | JAG1 | [72] | |
NOTCH2 | |||||
Wnt signal pathway | Robinow syndrome | [108, 109] | ROR2 | [121] | |
Chromatin remodeling Cell cycle, DNA repair |
Cell cycle | Schimke immuno-osteo dysplasia | [110, 111] | SMARCAL1 | [122] |
MOPDII | [112, 113] | PCNT | [112] | ||
Seckel syndrome | [114] | ATR | [123] | ||
RBBP8 | |||||
CENPJ | |||||
CEP63 | |||||
NIN | |||||
DNA repair Angiogenesis |
BRCA1 complex BRISC complex |
X-linked moyamoya syndrome | [88] | BRCC3 | ibid. [88] |
Inflammation | Inflammation activated thrombosis | Sneddon’s syndrome | [66–69] | CECR1 | [124] |
Excessive Type I interferon production | Aicardi–Goutieres syndrome | [65] | SAMHD1 | [65] | |
TRX1 | |||||
ACP5 | |||||
Vascular smooth muscle cell dysfunction | eNOS production | Moyamoya and achalasia syndrome | [71] | GUCY1A3 | ibid. [71] |
Excess proliferation | Thoracic aortic aneurysm and dissection | [70] | ACTA2 | ibid. [70] | |
Coagulopathy | Thrombosis | Sickel cell disease | [73] | β-globin gene | |
Protein S | [115, 116] | Protein S | |||
Protein C | [74, 75] | Protein C | |||
Thrombotic Thrombocytopeic Purpura | [76] | ADAMTS13 |